Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Fresenius Medical Care KGAA ST (FMEG)

Frankfurt
Currency in EUR
45.73
+0.17(+0.37%)
Closed

FMEG Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa17,476.5617,859.0617,618.6919,398.0219,453.62
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.62%+2.19%-1.35%+10.1%+0.29%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa12,080.712,321.6212,845.6614,504.3314,528.61
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa5,395.855,537.454,773.034,893.694,925.01
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.68%+2.62%-13.8%+2.53%+0.64%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa30.87%31.01%27.09%25.23%25.32%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa3,112.33,159.742,869.23,355.743,401.44
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+4.76%+1.52%-9.19%+16.96%+1.36%
aa.aaaa.aaaa.aaaa.aaaa.aa168.03193.77220.78228.62231.97
aa.aaaa.aaaa.aaaa.aaaa.aa2,944.272,965.962,772.833,170.373,196.34
aa.aaaa.aaaa.aaaa.aaaa.aa---124.41-43.25-26.86
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa2,283.552,377.711,903.831,537.951,523.56
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.57%+4.12%-19.93%-19.22%-0.94%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa13.07%13.31%10.81%7.93%7.83%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-429.44-368.02-280.43-292.48-336.42
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-42.64%+14.3%+23.8%-4.3%-15.03%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-491.06-409.98-353.6-360.14-424.64
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa61.6241.9673.1767.6688.22
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa73.6894.5282.2829.7386.29
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,927.792,104.211,705.671,275.21,273.43
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa---8.6347.174.84
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa4.0226.16---
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,840.111,936.391,571.861,219.281,033.02
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-32.76%+5.23%-18.83%-22.43%-15.28%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa10.53%10.84%8.92%6.29%5.31%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa401.61500.56352.83324.95300.56
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa1,438.51,435.831,219.03894.33732.46
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-238.88-271.46-249.72-220.92-233.46
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,199.621,164.38969.31673.41499
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-39.47%-2.94%-16.75%-30.53%-25.9%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa6.86%6.52%5.5%3.47%2.57%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,199.621,164.38969.31673.41499
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.963.963.312.31.7
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-38.7%-0.09%-16.44%-30.6%-25.94%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.963.963.312.31.7
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-38.6%-0.01%-16.44%-30.6%-25.97%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa302.69294.06292.94293.25293.41
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa302.75294.28293.07293.25293.41
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa1.21.341.351.121.19
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2.56%+11.67%+0.75%-17.04%+6.25%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa3,136.683,260.582,798.722,449.762,379.14
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+7.84%+3.95%-14.16%-12.47%-2.88%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa17.95%18.26%15.88%12.63%12.23%
EBIT
aa.aa